Antibody Citations
OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.
Search citations by gene symbols or target names
Here are some of the recent papers making use of OriGene products by fellow researchers.
| Target | Research Paper | Journal | Product | SKU |
|---|---|---|---|---|
| MRC1 | The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT | Crit Care, 2019 Aug | Antibody | AM05589PU-S |
| MRC1 | The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms | J. Leukoc. Biol., 2019 Jun | Antibody | SM1857P |
| MRC1 | The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation. | Liver international : official journal of the International Association for the Study of the Liver, 2017 Dec | Antibody | AM05589PU-S |
| MRC1 | Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF) | J. Hepatol., 2017 Nov | Antibody | AM05589PU-S |
| MRC1 | A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness | Clin. Chem. Lab. Med., 2016 Mar | Antibody | AM05589PU-S |
| MRC1 | Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process | Sci Rep, 2016 Mar | Antibody | SM1857PS |
| MRC1 | Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process | Sci Rep, 2016 Mar | Antibody | SM1857P |
| MRC1 | The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma | Leuk. Res., 2015 Jun | Antibody | AM05589PU-N |
| MRC1 | A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness. | Clinical chemistry and laboratory medicine, 2014 Sep | Antibody | AM05589PU-N |
| MRI1 | Role for human arylamine N-acetyltransferase 1 in the methionine salvage pathway | Biochem. Pharmacol., 2016 Nov | Antibody | TA500433S |
| MRI1 | Role for human arylamine N-acetyltransferase 1 in the methionine salvage pathway | Biochem. Pharmacol., 2016 Nov | Antibody | TA500433 |
| MRNIP | MRNIP condensates promote DNA double-strand break sensing and end resection | Nature Communications, 2022 May | Antibody | TA330650 |
| MRP3 | Metabolism and disposition of corylifol A from Psoralea corylifolia: metabolite mapping, isozyme contribution, species differences and identification of efflux transporters for corylifol A-O-glucuronide in HeLa1A1 cells | Xenobiotica, 2020 Apr | Antibody | TA314800 |
| MRP3 | Circadian Clock Gene Bmal1 Regulates Bilirubin Detoxification: A Potential Mechanism of Feedback Control of Hyperbilirubinemia | Theranostics, 2019 Jul | Antibody | TA314800 |
| MRP3 | The Efflux Mechanism of Fraxetin-O-Glucuronides in UGT1A9-Transfected HeLa Cells: Identification of Multidrug Resistance-Associated Proteins 3 and 4 (MRP3/4) as the Important Contributors | Front Pharmacol, 2019 May | Antibody | TA314800 |
| MRP3 | Mechanism of the efflux transport of demethoxycurcumin-O-glucuronides in HeLa cells stably transfected with UDP-glucuronosyltransferase 1A1 | PLoS ONE, 2019 May | Antibody | TA314800 |
| MRP3 | Sulfation disposition of liquiritigenin in SULT1A3 overexpressing HEK293 cells: The role of breast cancer resistance protein (BCRP) and multidrug resistance-associated protein 4 (MRP4) in sulfate efflux of liquiritigenin | Eur J Pharm Sci, 2018 Nov | Antibody | TA314800 |
| MRP3 | Efflux excretion of bisdemethoxycurcumin-O-glucuronide in UGT1A1-overexpressing HeLa cells: Identification of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins 1 (MRP1) as the glucuronide transporters | Biofactors, 2018 Oct | Antibody | TA314800 |
| MRP3 | The roles of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated proteins (MRPs/ABCCs) in the excretion of cycloicaritin-3-O-glucoronide in UGT1A1-overexpressing HeLa cells | Chem. Biol. Interact., 2018 Sep | Antibody | TA314800 |
| MRP3 | Chemical inhibitors and stable knock-down of efflux transport leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: The role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) i | Food & Function, 2017 Dec | Antibody | TA314800 |
| MRP3 | Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) Controls Efflux Transport of Hesperetin Sulfates in Sulfotransferase 1A3-Overexpressing Human Embryonic Kidney 293 Cells | Drug Metab. Dispos., 2015 Oct | Antibody | TA314800 |
| MRP3 | Stable Knock-down of Efflux Transporters Leads to Reduced Glucuronidation in UGT1A1-Overexpressing HeLa Cells: The Evidence for Glucuronidation-Transport Interplay | Mol. Pharm., 2015 Apr | Antibody | TA314800 |
| MRP3 | Characterization of Chrysin Glucuronidation in UGT1A1-Overexpressing HeLa Cells: Elucidating the Transporters Responsible for Efflux of Glucuronide | Drug Metab. Dispos., 2015 Jan | Antibody | TA314800 |
| MRP5 | Sulfation disposition of liquiritigenin in SULT1A3 overexpressing HEK293 cells: The role of breast cancer resistance protein (BCRP) and multidrug resistance-associated protein 4 (MRP4) in sulfate efflux of liquiritigenin | Eur J Pharm Sci, 2018 Nov | Antibody | TA322563 |
| MRP5 | The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells | Cell Death Dis, 2017 Mar | Antibody | TA322563 |
| MRP5 | Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) Controls Efflux Transport of Hesperetin Sulfates in Sulfotransferase 1A3-Overexpressing Human Embryonic Kidney 293 Cells | Drug Metab. Dispos., 2015 Oct | Antibody | TA322563 |
| MRP8/14 | Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder | World J Urol., 2013 Dec | Antibody | AP33370BT-S |
| MRP8/14 | Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder | World J Urol., 2013 Dec | Antibody | AP33370BT-N |
| MRPL15 | Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer | Frontiers in oncology, 2021 May | Antibody | TA807480 |
| MS4A1 | GSK-J4 Inhibition of KDM6B Histone Demethylase Blocks Adhesion of Mantle Cell Lymphoma Cells to Stromal Cells by Modulating NF-κB Signaling | Cells, 2023 Aug | Antibody | UM800001 |
| MS4A1 | Porphyromonas Gingivalis Load is Balanced by 0.20% Chlorhexidine Gel. A Randomized, Double-Blind, Controlled, Microbiological and Immunohistochemical Human Study | J Clin Med, 2020 Jan | Antibody | TA800385 |
| MS4A1 | CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells | Oncogene, 2017 May | Antibody | UM800001 |
| MS4A1 | Oligodendroglioma metastasis to the bone marrow mimicking multiple myeloma: A case report | Oncol Lett, 2016 Jul | Antibody | TA800385 |
| MS4A1 | T cell receptor rearrangements in a patient with γ-heavy chain disease: A case report | Oncology Letters, 2016 Jun | Antibody | TA800394 |
| MS4A1 | B-cell lymphoma with Mott cell differentiation in a cat. | Veterinary clinical pathology, 2016 Mar | Antibody | TA368419 |
| MS4A1 | Vaccine Induction of Lymph Node–Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques | The Journal of immunology, 2016 Feb | Antibody | TA305713 |
| MS4A1 | M2 Polarized Macrophages and Giant Cells Contribute to Myofibrosis in Neuromuscular Sarcoidosis | The American Journal of Pathology, 2011 Mar | Antibody | CF800385 |
| MSH2 | Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases. | Human pathology, 2020 Oct | Antibody | CF814210 |
| MSH2 | Isolated Langerhans cell histiocytosis of the stomach: a case report and literature review | International Journal of Clinical and Experimental Pathology, 2018 Dec | Antibody | CF814210 |
| MSH2 | Case Report Malignant glomus tumor of the ileum mimicking GIST with distant metastasis without BRAF V600E mutation | Int J Clin Exp Pathol, 2018 Oct | Antibody | DM332 |
| MSH6 | Clinicopathological analysis of primary carcinoid tumour of the ovary arising in mature cystic teratomas | The Journal of International Medical Research, 2021 Aug | Antibody | UM800148 |
| MSH6 | Pathological prognostic factors of pseudomyxoma peritonei: comprehensive clinicopathological analysis of 155 cases. | Human pathology, 2020 Oct | Antibody | DM429 |
| MSH6 | Isolated Langerhans cell histiocytosis of the stomach: a case report and literature review | International Journal of Clinical and Experimental Pathology, 2018 Dec | Antibody | DM429 |
| MSH6 | Mismatch repair-deficient status associates with favorable prognosis of Eastern Chinese population with sporadic colorectal cancer | Oncol Lett, 2018 Mar | Antibody | TA326879 |
| MSI2 | Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway | J. Exp. Clin. Cancer Res., 2019 Dec | Antibody | TA506196 |
| Msln | An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer | Journal for Immunotherapy of Cancer, 2023 Mar | Antibody | AM26533AF-N |
| MSLN | Early administration of amatuximab, a chimeric high-affinity anti-mesothelin monoclonal antibody, suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model | Investigational new drugs, 2021 Apr | Antibody | TA308767 |
| MSLN | Early administration of amatuximab suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model | Research Square, 2021 Mar | Antibody | TA308767 |
| MSMB | Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing | Gene, 2020 Oct | Antibody | TA501072 |
| MSMB | Validation of Prostate Cancer Risk Variants by CRISPR/Cas9 Mediated Genome Editing | bioRxiv, 2018 Jun | Antibody | TA501072S |
Germany
Japan
United Kingdom
China